Major Insider Purchases (February 2026)
Following a transformative financing round on February 12, 2026, several high-ranking insiders and the company’s largest shareholder made significant stock acquisitions at an average price of $0.40 per share:
Glen A. Taylor (Major Shareholder): Purchased 18,750,000 shares for a total value of $7.5 million.
Charles Brynelsen (Director): Acquired 1,000,000 shares worth $400,000.
Mona Chetan Patel (Director): Bought 312,500 shares valued at $125,000.
Robert Potashnick (Interim CFO): Purchased 212,500 shares for $85,000.
Susan Kantor (Director): Acquired 96,150 shares for $38,460.
Brent T. Lucas (CEO): Purchased 62,500 shares for $25,000.
Key Insider Trends
Alignment of Interests: Total insider ownership currently stands at approximately 34.5% ($26.56M value), suggesting strong alignment between management and shareholders.
Confidence Signal: Analysts at Simply Wall St noted that Taylor’s massive purchase increased his personal holding by 241%, signaling extreme confidence in the company's clinical trial progress.
Zero Selling: There have been no recorded insider sales in the past year, which is often viewed as a bullish indicator by investors.
----------------------
Kiwi
Market Data 
Markets 
